200,000+ products from a single source!
sales@angenechem.com
CAS No: 1232416-25-9 Catalog No: AG000K80 MDL No:MFCD27976794
Title | Journal |
---|---|
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses. | Cancer research 20141201 |
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. | Cell death & disease 20121201 |
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents. | Journal of medicinal chemistry 20110414 |
© 2019 Angene International Limited. All rights Reserved.